Duarte; City of Hope
COG AALL0232: High Risk B-Precursor Acute Lymphoblastic Leukemia
Duarte; City of Hope
SWOG S0325: A Phase IIB Study of Molecular Responses to Imatinib at Standard or Increased Doses for Previously Untreated Patients with Chronic Myelogenous Leukemia in Chronic Phase
Duarte; City of Hope
A Phase II Study of LBH589, a Novel Histone Deacetylase Inhibitor, in Relapsed and Refractory Adult Patients with Acute Lymphoblastic Leukemia (ALL)and Acute Myelogenous Leukemia, (AML)
Duarte; City of Hope
A Multi-Center, Open-Label Phase I Study of Single Agent RO5045337 Administered Orally in Patients with Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)in Blast Phase, or Refractory Chronic Lymphocytic Leukemia/Small Cell Lymphocytic Lymphoma (CLL/SCLL)
Duarte; City of Hope
Understanding the Barriers and Facilitators to Adherence to Oral Chemotherapy in Youth with Acute Lymphoblastic Leukemia
Duarte; City of Hope
COG AALL03N1: Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia
Duarte; City of Hope
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy
Duarte; City of Hope
SWOG 9007: Cytogenetic Studies In Leukemia Patients
Duarte; City of Hope
SWOG S0333: A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed Non-L3 Adult Acute Lymphoblastic Leukemia with Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy
Duarte; City of Hope
BMT CTN 0303: A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+Enriched, T Cell Depleted Peripheral Blood Stem Cells Isolated by The CliniMACS System in The Treatment of Patients With AML in First or Second Morphologic Complete Remission
Duarte; City of Hope
Allogeneic Stem Cell Transplantation with a Novel Conditioning Therapy Helical Tomotherapy, Melphalan, and Fludarabine in Hematological Malignancies
Duarte; City of Hope
Phase II Trial Utilizing Idarubicin in Combination with High-Dose Ara-C for Induction Therapy for Adult Acute Myelogenous Leukemia
Duarte; City of Hope
PHI-57 NCI# 7689: Phase I Trial of GTI2040 in Relapsed, Refractory, or High Risk Leukemia and Myelodysplasia
Duarte; City of Hope
SWOG S9910: Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary
Duarte; City of Hope
T2005-003: A Study of Bortezomib with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
Duarte; City of Hope
A Phase II Study of Rituximab-ABVD in Classical Hodgkin's Lymphoma
Duarte; City of Hope
COG #AAML0531: Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents and Young Adults
Duarte; City of Hope
COG AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Duarte; City of Hope
Molecular Pathogenesis of Therapy-Related Leukemia
Duarte; City of Hope
BMT CTN #0501: Multi-Center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood Transplantation in Pediatric Patients with High Risk Leukemia and Myelodysplasia
Duarte; City of Hope
Molecular Pathogenesis of Acute Leukemia and Myelodysplasia
Duarte; City of Hope
Mechanisms of Response and Resistance to STI571 in CML
Duarte; City of Hope
COG AALL03B1: Classification of Acute Lymphoblastic Leukemia
Duarte; City of Hope
Acquisition of Leukapheresed Peripheral Blood Mononuclear Cells from Healthy Donors for use as Support Cells in Ex-Vivo T Cell Expansions
Duarte; City of Hope
Immunophenotype and Function of Bone Marrow-Infiltrating Lymphocytes in Patients with Myeloid Leukemias
Bronx; Biomedical Research Alliance of New York
Acute Lymphocytic Leukemia (ALL) - Refractory or Relapsed
Bronx; Biomedical Research Alliance of New York
Leukemia - Acute Lymphocytic (ALL)
Lake Success; Biomedical Research Alliance of New York
Acute Promyelocytic Leukemia (APL) - Adults
Manhasset; Biomedical Research Alliance of New York
An experimental study to determine the dosage and safety of a study drug in patients with leukemia.
New Hyde Park; Biomedical Research Alliance of New York
A study to evaluate the tolerability of a study drug to help people with B-cell lymphocytic leukemia (B-CLL)
New York; Biomedical Research Alliance of New York
Mount Sinai Medical Center is recruiting subjects with chronic myeloid leukemia who are in blast crisis, accelerated phase, or chronic phase to participate in a clinical study to determine the safety of an experimental drug.
New York; Columbia University Medical Center
Peripheral Blood Stem Cell Mobilization and Storage in Patients with Chronic Myelogenous Leukemia in Complete Cytogenetic Remission on Imatinib.
New York; Mount Sinai Medical Center
Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients with Chronic Lymphocytic Leukemia Previously Treated with Fludarabine
New York; Columbia-Presbyterian Medical Center
Study of donor leukocyte infusions in patients with recurrent or persistent hematological malignancies after allogeneic bone marrow transplantation.
New York; Columbia-Presbyterian Medical Center
Study of the use of peripheral blood stem cells for allogeneic transplantation (PBSCT) in patients with advanced hematological malignancies at increased risk of relapse or transplant-related mortality
New York; Columbia-Presbyterian Medical Center
Study of autografting for advanced phase chronic myeloid leukemia
New York; Columbia-Presbyterian Medical Center
Study of transplantation using umbilical cord and placental blood
New York; Mount Sinai Medical Center
A Phase I-II Pilot Study of Divalproex Sodium and All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia (except M3, FAB Classification)
